Shareholding disclosure

Consonance Capital Management LP

Declared position

6.01%

Threshold

Crossed upwards

Timeline

Published

08.07.2014

Transaction

03.07.2014

Voting rights breakdown

Voting rights acquired6.01%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAE77000A6

Beneficial owner

Consonance Capital Management LP

Declared address

Consonance Capital Management LP, New York, NY 10019

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Consonance Capital Management LP

Santhera Pharmaceuticals Holding AG08.07.2014TAE77000A6

Disclosure summary

Consonance Capital Management LP disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 08.07.2014, at 6.01% of voting rights. Notice category: Single shareholder.

Disclosed position

6.01%

Voting rights acquired

Voting rights acquired6.01%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Consonance Capital Management LP disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 08.07.2014.

Publication date08.07.2014

Transaction date03.07.2014

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerConsonance Capital Management LP

Declared addressConsonance Capital Management LP, New York, NY 10019

CategorySingle shareholder

Voting rights acquired6.01%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAE77000A6

Source: SIX Exchange Regulation · Publication date: 08.07.2014

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open